SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : American Home Products AHP -- Ignore unavailable to you. Want to Upgrade?


To: Pancho Villa who wrote (74)3/27/1998 7:10:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 169
 
Last night LGND announced AHP's IND filing for TSE424. TSE424 is a SERM that will compete with SBH's Idoxifene, LLY's Evista (Raloxifene), and PFE's Droloxifene and CP-366,156. I have linked the press release to the AHP Alliance table at
home.att.net as well as the TSE424 Clinical Trials table at
home.att.net



To: Pancho Villa who wrote (74)6/2/1998 7:17:00 AM
From: Henry Niman  Read Replies (1) | Respond to of 169
 
I have updated the AHP/MTC Merger table at home.att.net with news reports from a variety of sources.